Tumor biology, treatment patterns, and recurrence in breast cancer patients aged 70–79 vs ≥ 80 years: a large-scale registry analysis
Clinical and biological differences between women aged 70-79 and those ≥ 80 underscore the need for age-adapted, individualized BC management. Treatment decisions should carefully balance expected benefit against comorbidity burden and functional status. Refining age-specific treatment strategies may help to improve outcomes and quality of life, although this analysis cannot determine the effects of specific strategies in this growing patient population.
Authors
- Simone Schrodi (ORCID: https://orcid.org/0009-0007-1915-3524)
- Rachel Wuerstlein (ORCID: https://orcid.org/0000-0001-7268-0840)
- Maximiliane Burgmann
- Franziska Ganster (ORCID: https://orcid.org/0009-0009-9919-360X)
- N. Harbeck
- M. Braun
- Ch. Seifert
- T. Kolben
- S. Beyer
- S. Mahner
Institutions
- German Red Cross (DE)
- LMU Klinikum (DE)
- Krankenhaus vom Roten Kreuz (DE)
- Health and Safety Authority (IE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Archives of Gynecology and Obstetrics
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1007/s00404-026-08379-2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00